Faculty

Back
Lim Lee Ling

Prof Dr Lim Lee Ling

MalaysiaMY, Malaysia


Faculty

Executive Director of the Department of Clinical Research and Advancement at the Office of Deputy Vice Chancellor (Research & Innovation)

Universiti Malaya

Prof. Lim is Executive Director of the Department of Clinical Research and Advancement at the Office of Deputy Vice Chancellor (Research & Innovation), Universiti Malaya, Kuala Lumpur, Malaysia. She is a Senior Consultant Endocrinologist and former Head of the Diabetes Care Unit, Universiti Malaya (2022-2025). She also holds honorary positions at the Chinese University of Hong Kong and the Baker Heart and Diabetes Institute, Melbourne, Australia. 
As a clinician-scientist, Prof. Lim’s major areas of interest are cardiometabolic medicine (epidemiology, molecular, and implementation science).  Prof. Lim sits on the Scientific Work Groups of the American Diabetes Association/European Association for the Study of Diabetes (ADA/EASD) Precision Medicine in Diabetes Initiative and the World Health Organization (WHO) Global Diabetes Compact. She has published more than 130 peer-reviewed articles, including in The Lancet, Nature, Diabetes Care, and Science Bulletin. Prof. Lim has received several awards, including the 2025 Malaysia Scopus Research Star Award – Women in Research Excellence (STEM) Category, Universiti Malaya’s Top Cited 
Researcher 2024, World’s Top 2% Scientists by Stanford University for 4 consecutive years (2022-2025), and the European Foundation for the Study of Diabetes (EFSD) Albert Renold Fellowship, tenable at the University of Oxford, UK. She is an Editorial Board Member of several Tier 1 Web of Science-indexed journals. She is also the Vice President of Diabetes Malaysia (a country affiliate of the International Diabetes Federation) and the Council Member of the Malaysian Endocrine and Metabolic Society. 

SubscribeModalsubscribe success

SUBSCRIBE FOR CONGRESS UPDATES

Exciting updates are coming soon. Receive updates and important announcements straight into your inbox.